Detalles de la búsqueda
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682738
2.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358628
3.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920559
4.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180954
5.
The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life.
Support Care Cancer
; 27(12): 4697-4704, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949832
6.
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
Acta Oncol
; 56(4): 555-562, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28068151
7.
Rediscovering Secondary Tumors of the Prostate in the Molecular Era.
Adv Anat Pathol
; 23(3): 170-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27058245
8.
Metastatic castration-resistant prostate cancer: time for innovation.
Future Oncol
; 11(1): 91-106, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25572785
9.
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications.
Crit Rev Oncol Hematol
; 197: 104328, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490281
10.
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey.
Tumori
; : 3008916241236279, 2024 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38462772
11.
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Sci Rep
; 14(1): 4949, 2024 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418470
12.
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis.
Clin Genitourin Cancer
; 22(2): 56-67.e16, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37798164
13.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer
; : 102074, 2024 Mar 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38616147
14.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410103
15.
Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis.
Cancers (Basel)
; 15(9)2023 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37173901
16.
Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer.
Clin Genitourin Cancer
; 21(5): 509-516, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37500375
17.
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol
; 83(1): 82-89, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216658
18.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Cancers (Basel)
; 15(8)2023 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190322
19.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38010650
20.
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
iScience
; 26(11): 107970, 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37860695